These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 37143655)

  • 1. Preparation of graphene oxide-stabilized Pickering emulsion adjuvant for Pgp3 recombinant vaccine and enhanced immunoprotection against
    Zhao L; Shu M; Chen H; Shi K; Li Z
    Front Immunol; 2023; 14():1148253. PubMed ID: 37143655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chitosan particle stabilized Pickering emulsion/interleukin-12 adjuvant system for Pgp3 subunit vaccine elicits immune protection against genital chlamydial infection in mice.
    Shu M; Zhao L; Shi K; Lei W; Yang Y; Li Z
    Front Immunol; 2022; 13():989620. PubMed ID: 36505424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel use of graphene oxide quantum dots in a pickering emulsion as a Chlamydia trachomatis vaccine adjuvant.
    Zhao L; Shu M; Shi K; Tang S; Li Z
    Int Immunopharmacol; 2023 May; 118():110035. PubMed ID: 36958212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel chimeric recombinant FliC-Pgp3 vaccine promotes immunoprotection against Chlamydia muridarum infection in mice.
    Zhao L; Wang X; Li Z
    Int J Biol Macromol; 2024 Feb; 258(Pt 1):128723. PubMed ID: 38101679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccination with MIP or Pgp3 induces cross-serovar protection against chlamydial genital tract infection in mice.
    Luan X; Peng B; Li Z; Tang L; Chen C; Chen L; Wu H; Sun Z; Lu C
    Immunobiology; 2019 Mar; 224(2):223-230. PubMed ID: 30558842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intranasal vaccination with a secreted chlamydial protein enhances resolution of genital Chlamydia muridarum infection, protects against oviduct pathology, and is highly dependent upon endogenous gamma interferon production.
    Murthy AK; Chambers JP; Meier PA; Zhong G; Arulanandam BP
    Infect Immun; 2007 Feb; 75(2):666-76. PubMed ID: 17118987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Plasmid-Encoded pGP3 Promotes
    Zhang T; Huo Z; Ma J; He C; Zhong G
    Infect Immun; 2019 Mar; 87(5):. PubMed ID: 30858342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of Pgp3 vaccination for
    Peng B; Zhong S; Hua Y; Luo Q; Dong W; Wang C; Li Z; Yang C; Lei A; Lu C
    Front Immunol; 2022; 13():1018774. PubMed ID: 36466885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection promoted by pGP3 or pGP4 against Chlamydia muridarum is mediated by CD4(+) cells in C57BL/6N mice.
    Mosolygó T; Szabó AM; Balogh EP; Faludi I; Virók DP; Endrész V; Samu A; Krenács T; Burián K
    Vaccine; 2014 Sep; 32(40):5228-33. PubMed ID: 25077421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chlamydial plasmid-encoded virulence factor Pgp3 interacts with human cathelicidin peptide LL-37 to modulate immune response.
    Hou S; Sun X; Dong X; Lin H; Tang L; Xue M; Zhong G
    Microbes Infect; 2019; 21(1):50-55. PubMed ID: 29959096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chlamydia muridarum T cell antigens and adjuvants that induce protective immunity in mice.
    Yu H; Karunakaran KP; Jiang X; Shen C; Andersen P; Brunham RC
    Infect Immun; 2012 Apr; 80(4):1510-8. PubMed ID: 22290151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cationic Nanoparticle-Stabilized Vaccine Delivery System for the H9N2 Vaccine to Promote Immune Response in Chickens.
    Zhang Y; Zhu T; Xu S; Gu P; Cai G; Peng S; Liu Z; Yang Y; Hu Y; Liu J; Wang D
    Mol Pharm; 2023 Mar; 20(3):1613-1623. PubMed ID: 36795759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A strong adjuvant based on glycol-chitosan-coated lipid-polymer hybrid nanoparticles potentiates mucosal immune responses against the recombinant Chlamydia trachomatis fusion antigen CTH522.
    Rose F; Wern JE; Gavins F; Andersen P; Follmann F; Foged C
    J Control Release; 2018 Feb; 271():88-97. PubMed ID: 29217176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody responses to
    Yu H; Geisler WM; Dai C; Gupta K; Cutter G; Brunham RC
    Front Cell Infect Microbiol; 2024; 14():1342621. PubMed ID: 38371301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of Squalene-Based Oil-in-Water Emulsion Adjuvants Using a Self-Emulsifying Drug Delivery System for Enhanced Antigen-Specific Antibody Titers.
    Chae GE; Kim DW; Jin HE
    Int J Nanomedicine; 2022; 17():6221-6231. PubMed ID: 36531114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chlamydia muridarum T-cell antigens formulated with the adjuvant DDA/TDB induce immunity against infection that correlates with a high frequency of gamma interferon (IFN-gamma)/tumor necrosis factor alpha and IFN-gamma/interleukin-17 double-positive CD4+ T cells.
    Yu H; Jiang X; Shen C; Karunakaran KP; Jiang J; Rosin NL; Brunham RC
    Infect Immun; 2010 May; 78(5):2272-82. PubMed ID: 20231405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and characterization of pickering emulsion stabilized by lovastatin nanoparticles for vaccine adjuvants.
    Zhang Y; Song Z; Zhang Z; Zhang T; Gu P; Feng Z; Xu S; Yang Y; Wang D; Liu Z
    Int J Pharm; 2024 Mar; 653():123901. PubMed ID: 38368969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chlamydia Deficient in Plasmid-Encoded Glycoprotein 3 (pGP3) as an Attenuated Live Oral Vaccine.
    Zhou Z; Tian Q; Wang L; Zhong G
    Infect Immun; 2022 Mar; 90(3):e0047221. PubMed ID: 35100010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chlamydia trachomatis Plasmid Gene Protein 3 Is Essential for the Establishment of Persistent Infection and Associated Immunopathology.
    Yang C; Kari L; Lei L; Carlson JH; Ma L; Couch CE; Whitmire WM; Bock K; Moore I; Bonner C; McClarty G; Caldwell HD
    mBio; 2020 Aug; 11(4):. PubMed ID: 32817110
    [No Abstract]   [Full Text] [Related]  

  • 20. Protection against genital tract Chlamydia trachomatis infection following intranasal immunization with a novel recombinant MOMP VS2/4 antigen.
    Hadad R; Marks E; Kalbina I; Schön K; Unemo M; Lycke N; Strid Å; Andersson S
    APMIS; 2016 Dec; 124(12):1078-1086. PubMed ID: 27859689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.